Although the significance of neuroinflammation in the pathogenesis and treatment of AD remains controversial, researchers have given substantial attention to exploring the link between TREM2, gut microbiota, mitochondrial dysfunction, exosomes, and inflammation. This evidence concerns the gene TREM2 and Alzheimer disease.